For these patients, a medication that addresses both concerns simultaneously is ideal
While some individuals report an increase in GERD symptoms, others experience no change or even an improvement, potentially due to weight loss
Some healthcare providers may choose to implement a stepwise dose reduction (for example, decreasing from 15 mg to 10 mg to 5 mg over several weeks) not because tapering is pharmacologically required, but to allow time for: Transitioning to alternative therapies Implementing lifestyle modifications Monitoring metabolic parameters Adjusting other medications Psychological preparation for treatment changes This approach represents clinical judgment rather than medical necessity
More serious side effects include pancreatitis, changes in vision, low blood sugar (hypoglycemia), allergic reactions, acute kidney injury, and severe stomach problems
There is no lawful route to be supplied BPC-157 for human use in the UK